Use of levonorgestrel as an effective means of contraception in the white-faced saki (Pithecia pithecia)

Zoo Biology

Volumn 21, Issue 1, 2002, Pages 49-57

  Savage, Anne ^a,b   Zirofsky, Dara S ^b   Shideler, Susan E ^c   Smith, Tessa E ^a   Lasley, Bill L ^c  

^a DISNEY S ANIMAL KINGDOM   (United States)

^b Roger Williams Park Zoo   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cebids; Contraceptives; Levonorgestrel (LNG); New World primates

Indexed keywords

INSERTION SEQUENCES; PITHECIA; PITHECIA PITHECIA; PRIMATES;

EID: 0036243654     PISSN: 07333188     EISSN: None     Source Type: Journal    
DOI: 10.1002/zoo.10006     Document Type: Article

References (26)

1. Asa CS, Porton I, Baker AM, Plotka ED. 1996. Contraception as a management tool for controlling surplus animals. In: Kleiman DG, Allen ME, Thompson KV, Lumpkin S, editors. Wild animals in captivity: principles and techniques. Chicago: University of Chicago Press. p 451-67.
2. Baldwin CJ, Peter AT, Bosu WTK, Dubielzig RR. 1994. The contraceptive effects of levonorgestrel in the domestic cat. Lab Anim Sci 44:261-9.
3. Bettinger T, Cougar D, Rick Lee D, Lasley BL, Wallis J. 1997. Ovarian hormone concentrations and genital swelling patterns in female chimpanzees with Norplant implants. Zoo Biol 16:209-23.
4. Brache V, Alvarez-Sanchez F, Faundes A, Tejada AS, Cochon L. 1990. Ovarian endocrine function through five years of continuous treatment with Norplant® subdermal contraceptive implants. Contraception 41:169-77.
5. Brache V, Blumenthal PD, Alvarez F, Dunson TR, Cochon L, Faundes A. 1999. Timing of onset of contraceptive effectiveness in Norplant® implant users II. Effect on the ovarian function in the first cycle of use. Contraception 59:245-51.
6. Brache V, Faundes A, Johansson E, Alaverez F. 1985. Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant® implants. Contraception 31:261-73.
7. Coe CL, Savage A, Bromley LJ. 1992. Phylogenetic influences on hormone levels across the primate order. Am J Primatol 28:81-100.
8. Croxatto HB, Diaz S, Miranda P, Elamsson K, Johansson EDB. 1981. Plasma levels of levonorgestrel in women during long-term use of Norplant. Contraception 23:197-209.
9. Croxatto HB, Diaz S, Pavez M, Miranda P, Brandeis A. 1982. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants. Acta Endocrinol 101:307-11.
10. Croxatto HB, Diaz S, Pavez M, Brandeis A. 1988. Estradiol plasma levels during long-term treatment with Norplant subdermal implants. Contraception 38:465-75.
11. Darney PD. 1994. Hormonal implants: contraception for a new century. Am J Obstet Gynecol 170:1536-43.
12. DeMatteo K. 1997 AZA Contraception Advisory Group Contraception Report: I. Primates. St. Louis Zoological Park, MO.
13. Faundes A, Brache V, Tejada AS, Cochon L, Sanchez FA. 1991. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants. Fertil Steril 56:27-31.
14. Kuhnz W, Fritzemeier C, Hegele-Hartung C, Krattenmacher R. 1995. Comparative progestational activity of norgestimate, levonorgestreloxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor. Contraception 51:131-9.
15. Lemus AE, Vilchis F, Damsky R, Chavez BA, Garcia GA, Grillasca I, Palacios GP. 1992. Mechanism of action of levonorgestrel: in vitro metabolism and specific interactions with steroid receptors in target organs. J Steroid Biochem Mol Biol 41:881-90.
16. Looper S, Anderson G, Sun Y, Shukla A, Lasley BL. 2001. Efficacy of levonorgestrel when administered as an irradiated, slow-release injectable matrix for a feline contraceptive. Zoo Biol 20:407-21.
17. Nisker JA, Kirk ME, Nunez-Troconis JT. Reduced incidence of rabbit endometrial neoplasia with levonorgestrel implant. Am J Obstet Gynecol 158:300-3.
18. Ratsula K, Toivonen J, Lahteenmaki P, Luukkainen T. 1989. Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device. Contraception 39:195-204.
19. Savage A, Lasley BL, Vecchio AJ, Miller AE, Shideler SE. 1995. Selected aspects of female white-faced saki (Pithecia pithecia) reproductive biology in captivity. Zoo Biol 14:441-52.
20. Shaaban MM, Segal S, Salem HT, Ghaneiman SA, Khalifa EA, Ahmed AG. 1993. Sonographic assessment of ovarian and endometrial changes during long-term Norplant® use and their correlation with hormonal levels. Fertil Steril 59:998-1002.
21. Shideler SE, Savage A, Ortuno AM, Moorman EA, Lasley BL. 1994. Monitoring female reproductive function by measurement of fecal estrogen and progesterone metabolites in the white-faced saki (Pithecia pithecia). Am J Primatol 32:95-108.
22. Shirly B, Bundren JC. 1995. Effects of levonorgestrel on capacity of mouse oocytes for fertilization and development. Contraception 52:209-14.
23. Taussky HH. 1954. A microcolormetric determination of creatine in urine by the Jaffe reaction. J Biol Chem 208:853-61.
24. Tell L, Shukla A, Munson L, Thosar S, Kass P, Stanton R, Needham M, Lasley BL. 1999. A comparison of the effects of slow release, injectable levonorgestrel and depot medroxyprogesterone acetate on egg production in Japanese quail (Cotumix cotumix japonica). J Avian Med Surg 13:23-31.
25. Telleria CM, Carrizo DG, Deis RP. 1994. Levonorgestrel inhibits luteinizing hormone-stimulated progesterone production in rat luteal cells. J Steroid Biochem Mol Biol 50:161-66.
26. Wise DL, Rosenkrantz H, Gregory JB, Esber HJ. 1980. Long-term controlled delivery of levonorgestrel in rats by means of small biodegradable cylinders. J Pharmacol 32:399-403.